IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Merit Medical Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire

LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Merit Medical Systems, Inc. (“Merit Medical” or “the Company”) (NASDAQ: MMSI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 26, 2019 and October 30, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 3, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Merit Medical’s integration of Cianna and Vascular Insights were months behind schedule, suffering from operational disruptions and reduced sales. The acquired companies had filled their pipeline before the merger to the extent that 2019 sales slowed substantially. The Company’s financial guidance for 2019 and 2020 did not have a solid basis in fact due to these problems. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Merit Medical, investors suffered damages.